Updated clinical overview on cardiac laminopathies: an electrical and mechanical disease
暂无分享,去创建一个
S. Benedetti | M. Ferrari | S. Sala | G. Peretto | C. D. Resta | L. Gigli | P. D. Bella
[1] M. Care,et al. Genetic Testing in Inherited Heart Diseases: Practical Considerations for Clinicians , 2017, Current Cardiology Reports.
[2] W. Tang,et al. Lamin A/C Cardiomyopathies: Current Understanding and Novel Treatment Strategies , 2017, Current Treatment Options in Cardiovascular Medicine.
[3] Hyun-Young Park. Hereditary Dilated Cardiomyopathy: Recent Advances in Genetic Diagnostics , 2017, Korean circulation journal.
[4] P. Piirilä,et al. Clinical disease presentation and ECG characteristics of LMNA mutation carriers , 2017, Open Heart.
[5] W. Stevenson,et al. Long-Term Arrhythmic and Nonarrhythmic Outcomes of Lamin A/C Mutation Carriers. , 2016, Journal of the American College of Cardiology.
[6] P. Ponikowski,et al. [2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure]. , 2016, Kardiologia polska.
[7] P. Kirchhof,et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[8] P. Kirchhof,et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. , 2016, European heart journal.
[9] L. Maggi,et al. Skeletal Muscle Laminopathies: A Review of Clinical and Molecular Features , 2016, Cells.
[10] W. Stevenson,et al. Multicenter Experience With Catheter Ablation for Ventricular Tachycardia in Lamin A/C Cardiomyopathy , 2016, Circulation. Arrhythmia and electrophysiology.
[11] R. Hershberger,et al. LMNA-Related Dilated Cardiomyopathy , 2016 .
[12] C. Simone,et al. Clinical and Functional Characterization of a Novel Mutation in Lamin A/C Gene in a Multigenerational Family with Arrhythmogenic Cardiac Laminopathy , 2015, PloS one.
[13] Claudio Passino,et al. Markers of fibrosis, inflammation, and remodeling pathways in heart failure. , 2015, Clinica chimica acta; international journal of clinical chemistry.
[14] E. Bertini,et al. LMNA-associated myopathies , 2014, Neurology.
[15] T. Edvardsen,et al. Risk prediction of ventricular arrhythmias and myocardial function in Lamin A/C mutation positive subjects. , 2014, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[16] M. Drazner,et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.
[17] D. Hedges,et al. Dilated cardiomyopathy: the complexity of a diverse genetic architecture , 2013, Nature Reviews Cardiology.
[18] Lluís Mont,et al. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). , 2013, European heart journal.
[19] A. Anastasakis,et al. A patient with ventricular tachycardia due to a novel mutation of the lamin A/C gene: case presentation and mini review. , 2013, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.
[20] L. Maggi,et al. Overlapping syndromes in laminopathies: a meta-analysis of the reported literature , 2013, Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology.
[21] I. Hausmanowa-Petrusewicz,et al. Advances in basic and clinical research in laminopathies , 2013, Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology.
[22] G. Bonne,et al. ‘State-of-the-heart’ of cardiac laminopathies , 2013, Current opinion in cardiology.
[23] B. Kennedy,et al. Phosphorylation of connexin43 on S279/282 may contribute to laminopathy-associated conduction defects. , 2013, Experimental cell research.
[24] A. Zwinderman,et al. Gender‐specific differences in major cardiac events and mortality in lamin A/C mutation carriers , 2013, European journal of heart failure.
[25] E. Rampersaud,et al. Temporal relationship of conduction system disease and ventricular dysfunction in LMNA cardiomyopathy. , 2013, Journal of cardiac failure.
[26] P. Golino,et al. Increased dispersion of ventricular repolarization in emery dreifuss muscular dystrophy patients , 2012, Medical science monitor : international medical journal of experimental and clinical research.
[27] S. Adam,et al. Nuclear lamin functions and disease. , 2012, Trends in genetics : TIG.
[28] Richard L. Frock,et al. Cardiomyocyte-Specific Expression of Lamin A Improves Cardiac Function in Lmna −/− Mice , 2012, PloS one.
[29] A. Zwinderman,et al. Lamin A/C mutation is independently associated with an increased risk of arterial and venous thromboembolic complications. , 2013, International journal of cardiology.
[30] E. Arbustini,et al. What Should the Cardiologist know about Lamin Disease? , 2012, Arrhythmia & electrophysiology review.
[31] M. Ashworth,et al. Mutations in the Lamin A/C gene mimic arrhythmogenic right ventricular cardiomyopathy. , 2012, European heart journal.
[32] A. Zwinderman,et al. Risk factors for malignant ventricular arrhythmias in lamin a/c mutation carriers a European cohort study. , 2012, Journal of the American College of Cardiology.
[33] S. Sideris,et al. Ventricular arrhythmias: from the electrophysiology laboratory to clinical practice. Part I: malignant ventricular arrhythmias. , 2011, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.
[34] P. Golino,et al. P-Wave Duration and Dispersion in Patients With Emery-Dreifuss Muscular Dystrophy , 2011, Journal of Investigative Medicine.
[35] K. Wahbi,et al. N-terminal Pro brain natriuretic peptide is a reliable biomarker of reduced myocardial contractility in patients with lamin A/C gene mutations. , 2011, International journal of cardiology.
[36] Jonathan T. Lu,et al. LMNA cardiomyopathy: cell biology and genetics meet clinical medicine , 2011, Disease Models & Mechanisms.
[37] J. Lötjönen,et al. Late gadolinium enhanced cardiovascular magnetic resonance of lamin A/C gene mutation related dilated cardiomyopathy , 2011, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[38] Pamela K. Mason,et al. Lamin A/C deficiency as a cause of familial dilated cardiomyopathy , 2009, Current opinion in cardiology.
[39] L. Tavazzi,et al. Long-term outcome and risk stratification in dilated cardiolaminopathies. , 2008, Journal of the American College of Cardiology.
[40] Michael Jerosch-Herold,et al. Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathy. , 2008, American journal of physiology. Heart and circulatory physiology.
[41] I. V. Van Gelder,et al. High yield of LMNA mutations in patients with dilated cardiomyopathy and/or conduction disease referred to cardiogenetics outpatient clinics. , 2007, American heart journal.
[42] E. Bertini,et al. Phenotypic clustering of lamin A/C mutations in neuromuscular patients , 2007, Neurology.
[43] Y. Pinto,et al. Severe myocardial fibrosis caused by a deletion of the 5' end of the lamin A/C gene. , 2007, Journal of the American College of Cardiology.
[44] S. Young,et al. Mouse models of the laminopathies. , 2007, Experimental cell research.
[45] Dudley J Pennell,et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. , 2006, Journal of the American College of Cardiology.
[46] R. Hetzer,et al. Genetic and phenotypic analysis of dilated cardiomyopathy with conduction system disease: Demand for strategies in the management of presymptomatic lamin A/C mutant carriers , 2006, European journal of heart failure.
[47] U. Nellessen,et al. Serial analysis of troponin I levels in patients with ischemic and nonischemic dilated cardiomyopathy , 2006, Clinical cardiology.
[48] J. Cleland,et al. Left ventricular morphology, global and longitudinal function in normal older individuals: a cardiac magnetic resonance study. , 2006, International journal of cardiology.
[49] V. Hombach,et al. Myocardial biopsy findings and gadolinium enhanced cardiovascular magnetic resonance in dilated cardiomyopathy , 2006, European journal of heart failure.
[50] Y. Pinto,et al. Primary prevention of sudden death in patients with lamin A/C gene mutations. , 2006, The New England journal of medicine.
[51] M. Laakso,et al. Novel mutations in the lamin A/C gene in heart transplant recipients with end stage dilated cardiomyopathy , 2005, Heart.
[52] F. Tezuka,et al. Electrophysiological and Histopathological Characteristics of Progressive Atrioventricular Block Accompanied by Familial Dilated Cardiomyopathy Caused by a Novel Mutation of Lamin A/C Gene , 2005, Journal of cardiovascular electrophysiology.
[53] Y. Pinto,et al. Often seen but rarely recognised: cardiac complications of lamin A/C mutations. , 2004, European heart journal.
[54] L. Tavazzi,et al. Loss of lamin A/C expression revealed by immuno-electron microscopy in dilated cardiomyopathy with atrioventricular block caused by LMNA gene defects , 2003, Virchows Archiv.
[55] L. Mestroni,et al. Natural history of dilated cardiomyopathy due to lamin A/C gene mutations. , 2003, Journal of the American College of Cardiology.
[56] Eloisa Arbustini,et al. Autosomal dominant dilated cardiomyopathy with atrioventricular block: a lamin A/C defect-related disease. , 2002, Journal of the American College of Cardiology.
[57] B. Eymard,et al. High Incidence of Sudden Death with Conduction System and Myocardial Disease Due to Lamins A and C Gene Mutation , 2000, Pacing and clinical electrophysiology : PACE.
[58] J. Seidman,et al. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. , 1999, The New England journal of medicine.
[59] D. Levy,et al. Distribution and categorization of echocardiographic measurements in relation to reference limits: the Framingham Heart Study: formulation of a height- and sex-specific classification and its prospective validation. , 1997, Circulation.
[60] H. Worman,et al. Structural organization of the human gene encoding nuclear lamin A and nuclear lamin C. , 1993, The Journal of biological chemistry.
[61] J. Ryan,et al. Evolution of a hereditary cardiac conduction and muscle disorder: a study involving a family with six generations affected. , 1986, Circulation.
[62] K. Stephens,et al. LMNA-Related Dilated Cardiomyopathy -- GeneReviews® , 2016 .
[63] T. Edvardsen,et al. Mechanical dispersion by strain echocardiography: a predictor of ventricular arrhythmias in subjects with lamin A/C mutations. , 2015, JACC. Cardiovascular imaging.
[64] Andrea Mazzanti,et al. [2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death]. , 2015, Kardiologia polska.
[65] J. Nielsen,et al. ESC Guidelines on cardiac pacing and cardiac resynchronization therapy , 2014 .
[66] M. Emdin,et al. CMR-verified interstitial myocardial fibrosis as a marker of subclinical cardiac involvement in LMNA mutation carriers. , 2013, JACC. Cardiovascular imaging.
[67] Biykem Bozkurt,et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. , 2013, Circulation.
[68] B. Funke,et al. Dilated cardiomyopathy , 2007, Archives of Disease in Childhood.
[69] L. A. Bonet,et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2012, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.
[70] T. Calvo,et al. Ac ce pte d m an us cri pt Aggregation functions based on penalties , 2010 .
[71] S. Raman,et al. Mid-myocardial fibrosis by cardiac magnetic resonance in patients with lamin A/C cardiomyopathy: possible substrate for diastolic dysfunction. , 2007, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[72] H. Crijns,et al. Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A/C mutations portend a high risk of sudden death? , 2004, Journal of Molecular Medicine.